-
MACHINE LEARNING-BASED PREDICTION FOR NEPHROTOXICITY IN ONCOLOGY PATIENTS WITH CHEMOTHERAPY
Mar 18, 2026, 21:38 PM -
INTEGRATING PREVENTIVE HEALTH STRATEGIES TO SLOW COGNITIVE DECLINE IN OLDER ADULTS
Mar 18, 2026, 21:38 PM -
MODELING THE LIFETIME BENEFITS OF ETEPLIRSEN IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Mar 18, 2026, 21:38 PM -
A STRUCTURED FRAMEWORK FOR CATEGORISING UNMET NEED IN HTA: APPLICATION TO SOLID TUMOR ASSESSMENTS ACROSS EIGHT OECD COUNTRIES
Mar 18, 2026, 21:38 PM -
CHARACTER STRENGTHS AND BURNOUT DIMENSIONS AMONG EMERGENCY CARE PROFESSIONALS IN HUNGARY: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
PREDICTING ENROLLMENT IN MEDICARE ADVANTAGE PRESCRIPTION DRUG PLANS AND STANDALONE PRESCRIPTION DRUG PLANS AMONG MEDICARE CANCER BENEFICIARIES: A MACHINE LEARNING STUDY
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING TO DIFFERENTIATE CONGESTIVE HEART FAILURE ONSET AMONG HIGH-RISK PATIENTS IDENTIFIED BY THE FRAMINGHAM RISK SCORE
Mar 18, 2026, 21:38 PM -
DESCRIPTION OF THE CHARACTERISTICS AND BURDEN OF NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN A SAMPLE OF ADULT PATIENTS IN THE USA: RESULTS FROM A REAL-WORLD SURVEY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
Mar 18, 2026, 21:38 PM -
THE ROLE OF URIC ACID AND GOUT IN THE DEVELOPMENT OF OSTEOPOROSIS
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE PHENYLKETONURIA-SYMPTOM SEVERITY AND IMPACTS SCALE (PKU-SSIS) IN ADULTS WITH PKU
Mar 18, 2026, 21:38 PM -
A NEXT-GENERATION FRAMEWORK FOR AI-AUGMENTED, SUBMISSION-GRADE LITERATURE REVIEWS: A MULTI-PROJECT ANALYSIS OF SPEED, ACCURACY, AND WORKFLOW EVOLUTION
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
DO MULTIPLE PRESENTATIONS AFFECT THE DURATION OF U.S. DRUG SHORTAGES?
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF CRS AND ICANS SEVERITY ACROSS SIX COMMERCIAL CAR-T THERAPIES
Mar 18, 2026, 21:38 PM -
EXPLORING THE POTENTIAL IMPACT OF THE INFLATION REDUCTION ACT’S PART D REDESIGN ON FORMULARY COVERAGE?IN COMPETITIVE CLASSES: 2024-2026
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF DAMOCTOCOG ALFA PEGOL VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS IN COLOMBIA, PERU AND COSTA RICA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ONCOLOGY MEDICINES IN LATIN AMERICA: AVAILABILITY AND TIME-TO-ACCESS ACROSS HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC LITERATURE REVIEW ON FINANCIAL BURDEN, FINANCIAL TOXICITY, OUTCOMES, POTENTIAL INTERVENTIONS, AND POLICIES ASSOCIATED WITH OUT-OF-POCKET MEDICATION AND HEALTHCARE EXPENSES AMONG OLDER PATIENTS IN THE US
Mar 18, 2026, 21:38 PM
